packagePatisiran

patisiran

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Patisiran is a medicine used to treat hereditary amyloidosis, a rare nerve-related condition. It is authorised in the European Union and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q40441442 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:patisiran
ATC codes:N07XX12
DrugBank:DB14582
Wikidata:Q40441442

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown